medigraphic.com
ISSN 1527-3172 (Electronic)

2015, Number 3

<< Back Next >>

MEDICC Review 2015; 17 (3)

Macrosomia predictors in infants born to cuban mothers with gestational diabetes

Cruz HJ, Grandía GR, Padilla LL, Rodríguez BS, Hernández GP, Lang PJ, Márquez-Guillén A

Language: English
References: 49
Page: 27-32
PDF size: 103.06 Kb.


ABSTRACT

INTRODUCTION Fetal macrosomia is the most important complication in infants of women with diabetes, whether preconceptional or gestational. Its occurrence is related to certain maternal and fetal conditions and negatively affects maternal and perinatal outcomes. The definitive diagnosis is made at birth if a newborn weighs › 4000g.
OBJECTIVE Identify which maternal and fetal conditions could be macrosomia predictors in infants born to Cuban mothers with gestational diabetes.
METHODS A case-control study comprising 236 women with gestational diabetes who bore live infants (118 with macrosomia and 118 without) was conducted in the América Arias University Maternity Hospital, Havana, Cuba, during 2002–2012. The dependent variable was macrosomia (birth weight › 4000g). Independent maternal variables included body mass index at pregnancy onset, overweight or obesity at pregnancy onset, gestational age at diabetes diagnosis, pregnancy weight gain, glycemic control, triglycerides and cholesterol. Fetal variables examined included third-semester fetal abdominal circumference, estimated fetal weight at ≥ 28 weeks (absolute and percentilized by Campbell and Wilkin, and Usher and McLean curves). Chi square was used to compare continuous variables (proportions) and the student t test (X ± SD) for categorical variables, with significance threshold set at p ‹ 0.05. ORs and their 95% CIs were calculated.
RESULTS Significant differences between cases and controls were found in most variables studied, with the exception of late gestational diabetes diagnosis, total fasting cholesterol and hypercholesterolemia. The highest OR for macrosomia were for maternal hypertriglyceridemia (OR 4.80, CI 2.34–9.84), third-trimester fetal abdominal circumference › 75th percentile (OR 7.54, CI 4.04–14.06), and estimated fetal weight › 90th percentile by Campbell and Wilkin curves (OR 4.75, CI 1.42–15.84) and by Usher and McLean curves (OR 8.81, CI 4.25–18.26).
CONCLUSIONS Most variables assessed were predictors of macrosomia in infants of mothers with gestational diabetes. They should therefore be taken into account for future studies and for patient management. Wide confidence intervals indicate uncertainty about the magnitude of predictive power.


REFERENCES

  1. Hawdon JM. Babies born after diabetes in pregnancy: what are the short- and longterm risks and how can we minimise them? Best Pract Res Clin Obstet Gynaecol. 2011 Feb;25(1):91–104.

  2. Mitanchez D, Burguet A, Simeoni U. Infants born to mother with gestational diabetes mellitus: mild neonatal effects, a long-term threat to global health. J Pediatr. 2014 Mar;164(3):445–50.

  3. Cruz J, Hernández P, Yanes M, Isla A. La macrosomía en el embarazo complicado con diabetes. Rev Centroamer Obstet Ginecol. 2009 Jan– Mar;14(1):5–10. Spanish.

  4. Šegregur J, Buković D, Milinović D, Orešković S, Panelić J, Župić T, et al. Fetal macrosomia in pregnant women with gestational diabetes. Coll Antropol. 2009 Dec;33(4):1121–7.

  5. Terrero Llago A, Venzant Massó M, Reyes Salazar IS, Hechavarría Rodríguez AA. Efecto de la diabetes gestacional sobre los resultados perinatales. MEDISAN [Internet]. 2005 [cited 2013 Dec];9(2). Available from: http://bvs.sld.cu/revis tas/san/vol9_2_05/san08205.htm. Spanish.

  6. Torres González C, Hernández Barrios E, Moreno Torres J, Rodríguez-Cabrera A, Vázquez Martínez V. Factores de riesgo para macrosomía en recién nacidos hijos de madre con diabetes gestacional. MediSur [Internet]. 2006 [cited 2013 Dec];4(1). Available from: http://medisur.sld .cu/index.php/medisur/article/view/172/4859#. Spanish.

  7. Cruz Hernández J, Vargas Torres I, Hernández P, Yanes Quesada M, Isla Valdés A, Rimbao Torres G. Macrosomía neonatal y diabetes gestacional. Rev Centroamer Obstet Ginecol. 2010 Oct– Dec;15(4):116–21. Spanish.

  8. Neff KJ, Walsh C, Kinsley B, Daly S. Serial fetal abdominal circumference measurements in predicting normal birth in gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):106–10.

  9. Campbell S, Wilkin D. Ultrasonic measurement of fetal abdomen circumference in the estimation of fetal weight. Br J Obstet Gynaecol. 1975 Sep;82(9):689–97.

  10. Usher R, McLean F. Intrauterine growth of liveborn Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr. 1969 Jun;74(6):901–10.

  11. Cruz Hernández J, Hernández García P, Yanes Quesada M, Rimbao Torres G, Lang Prieto J, Márquez Guillén A. Macrosomía neonatal en el embarazo complicado con diabetes. Rev Cubana Med Gen Integr [Internet]. 2008 Jul–Sep [cited 2013 Dec];24(3). Available from: http://scielo .sld.cu/scielo.php?script=sci_arttext&pid=S0864 -21252008000300006&lng=es. Spanish.

  12. Águila S, Breto A, Cabezas E, Delgado JJ, Santisteban S, editors. Nutrición en el embarazo. In: Obstetricia y perinatología. Diagnóstico y tratamiento. Havana: ECIMED; 2013. p. 77–106. Spanish.

  13. Águila S, Breto A, Cabezas E, Delgado JJ, Santisteban S, editors. Diabetes y embarazo. In: Obstetricia y perinatología. Diagnóstico y tratamiento. Havana: ECIMED; 2013. p. 306–21. Spanish.

  14. Klajnbard A, Szecsi PB, Colov NP, Andersen MR, Jørgersen M, Bjørngaard B, et al. Laboratory reference intervals during pregnancy, delivery and the early postpartum period. Clin Chem Lab Med. 2010 Feb;48(2):237–48.

  15. Águila S, Breto A, Cabezas E, Delgado JJ, Santisteban S, editors. Distocia de hombros. In: Obstetricia y perinatología. Diagnóstico y tratamiento. Havana: ECIMED; 2013. p. 269–72. Spanish.

  16. Tamura RK, Sabbagha RE. Percentile ranks of sonar fetal abdominal circumference measurements. Am J Obstet Gynecol. 1980 Nov 1;138(5):475–9.

  17. Shushan A, Ezra Y, Samueloff A. Early treatment of gestational diabetes reduces the rate of fetal macrosomia. Am J Perinatol. 1997 May;14(5):253–6.

  18. Szymańska M, Bomba-Opoń DA, Celińska AM, Weilgoś M. [Diagnostic of gestational diabetes mellitus and the prevalence of LGA (Large for Gestational Age)]. Ginekol Pol. 2008 Mar;79(3):177–81. Polish.

  19. García León L, Romero OL, Medina Landeta R, Hernández Cabrera J. Macrosomía fetal en la diabetes mellitus gestacional. Su relación con los factores de riesgo. Rev Méd Electrón [Internet]. 2007 [cited 2013 Dec];29(6). Available from: http://www.revmatanzas.sld.cu/revista%20 medica/ano%202007/vol6%202007/tema06 .htm. Spanish.

  20. Dang K, Homko C, Reece EA. Factors associated with fetal macrosomia in offspring of gestational diabetic women. J Matern Fetal Med. 2000 Mar–Apr;9(2):114–7.

  21. Briese V, Voight M, Hermanussen M, Wittwer- Backofen U. Morbid obesity: pregnancy risks, birth risks and status of the newborn. Homo. 2010 Feb;61(1):64–72.

  22. Lapolla A, Bonomo M, Dalfrà MG, Parretti E, Mannino D, Mello G, et al. Prepregnancy BMI infl uences maternal and fetal outcomes in women with isolated gestational hyperglycaemia: a multicenter study. Diabetes Metab. 2010 Sep;36(4):265–70.

  23. Ouzounian JG, Hernández GD, Korst LM, Montoro MM, Battista LR, Walden CL, et al. Pre-pregnancy weight and excess weight gain are risk factors for macrosomia in women with gestational diabetes. J Perinatol. 2011 Nov;31(11):717–21.

  24. Van Wootten W, Turner RE. The prevalence of macrosomia in neonates of gestational diabetic mothers: analysis of risk factors. J Acad Nutr Dietetics. 1999 Sep;99(9 Suppl):S132.

  25. Rodrigues Lima Kerche LT, Abbade JF, Araújo Costa RA, Vieira Cunha Rudge M, de Mattos Paranhos Calderon I. [Fetal macrosomia risk factors in pregnancies complicated by diabetes or daily hyperglycemia]. Rev Bras Ginecol Obstet. 2005;27(10):580–7. Portuguese.

  26. Cypryk K, Pertyńska-Marczewska M, Szymczak W, Zawadniak-Szalapska M, Wliczyński J, Lewiński A. [Overweight and obesity as common risk factors for gestational diabetes mellitus (GDM), perinatal macrosomy in offspring and type-2 diabetes in mother]. Przegl Lek. 2005;62(1):38–41. Polish.

  27. Álvarez Zapata D, Valdés Amador L, Santana Bacallao O, Lugo Alonso J. El exceso y el bajo peso corporal al nacimiento en hijos de madres con diabetes. Rev Cubana Obstet Ginecol. 2012;38(3):294–304. Spanish.

  28. Tanir HM, Sener T, Gürer H, Kaya M. A ten-year gestational diabetes mellitus cohort at a university clinic of the mid-Anatolian region of Turkey. Clin Exp Obstet Gynecol. 2005;32(4):241–4.

  29. Park JE, Park S, Daily JW, Kim SH. Low gestational weight gain improves infant and maternal pregnancy outcomes in overweight and obese Korean women with gestational diabetes mellitus. Gynecol Endocrinol. 2011 Oct;27(10):775– 81.

  30. Wong VW, Russell H. Weight gain during pregnancy in women with gestational diabetes: How little is too little? Diab Res Clin Pract. 2013 Nov;102(2):e32–4.

  31. Zawiejska A, Wender-Ozegowska E, Brazert J, Sodowski K. Components of metabolic syndrome and their impact on fetal growth in women with gestational diabetes mellitus. J Physiol Pharmacol. 2008 Sep;59 Suppl 4:S5–18.

  32. Lim EL, Burden T, Marshall SM, Davison JM, Blott MJ, Waught JSJ, et al. Intrauterine growth rate in pregnancies complicated by type 1, type 2 and gestational diabetes. Obstet Med. 2009 Mar;2(1):21–5.

  33. Yun Liu K, Chow JM, Sherry C. Early life obesity and diabetes: origins in pregnancy. Open J Endoc Metab Dis. 2013 Feb;3(1):1–12.

  34. Couch SC, Philipson EH, Bendel RB, Wijendran V, Lammi-Keefe CJ. Maternal and cord plasma lipid and lipoprotein concentrations in women with and without gestational diabetes mellitus. Predictors of birth weight? J Reprod Med. 1998 Sep;43(9):816–22.

  35. Whyte K, Kelly H, O´Dwyer V, Gibbs M, O´Higgins A, Turner MJ. Offspring birth weight and maternal fasting lipids in women screened for gestational diabetes mellitus (GDM). Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):67–70.

  36. Gopinath S, Varalakshmi G, Manoj K, Rubiya. Glycemic control and fetal abdominal circumference. Indian J Endocrinol Metab. 2012 Dec;16(Suppl 2):S445–6.

  37. Shaefer-Graf UM, Wendt L, Sacks DA, Kilavuz Ö, Gaber B, Metzner S, et al. How many sonograms are needed to reliably predict the absence of fetal overgrowth in gestational diabetes mellitus pregnancies? Diabetes Care. 2011 Jan;34(1):39–43.

  38. Schaefer-Graf UM, Kjos SL, Kilavuz Ö, Plagemann A, Brauer M, Dudenhausen JW, et al. Determinants of fetal growth at different periods of pregnancies complicated by gestational diabetes mellitus or impaired glucose tolerance. Diabetes Care. 2003 Jan;26(1):193–8.

  39. Bochner CJ, Medearis AL, Williams J 3rd, Castro L, Hobel CJ, Wade ME. Early third-trimester ultrasound screening in gestational diabetes to determine the risk of macrosomia and labor dystocia at term. Am J Obstet Gynecol. 1987 Sep;157(3):703–8.

  40. Tamura RK, Sabbagha RE, Depp R, Dooley SL, Socol ML. Diabetic macrosomia: accuracy of third trimester ultrasound. Obstet Gynecol. 1986 Jun;67(6):828–32.

  41. Kjos SL, Schaefer-Graf U, Sardesi S, Peters RK, Buley A, Xiang AH, et al. A randomized controlled trial utilizing glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care. 2001 Nov;24(11):1904–10.

  42. Díaz Salazar M, López Peña JG, García de Yegüez M, Herrera A, Meléndez M, Salas K. Cálculo de peso al nacer por ultrasonido en las embarazadas de alto riesgo. Salus [Internet]. 2011 Dec [cited 2013 Dec];15(3):13–8. Available from: http://www.scielo.org.ve/pdf/s/v15n3/art06 .pdf. Spanish.

  43. Nelson L, Wharton B, Grobman WA. Prediction of large for gestational age birth weights in diabetic mothers based on early third-trimester sonography. J Ultrasound Med. 2011 Dec;30(12):1625–8.

  44. Wyse LJ, Jones M, Mandel F. Relationship of glycosylated hemoglobin, fetal macrosomia, and birthweight macrosomia. Am J Perinatol. 1994 Jul;11(4):260–2.

  45. Vedavathi KJ, Swamy RM, Shekharappa KR, Venkatesh G, Veerananna HB. Infl uence of gestational diabetes mellitus on fetal growth parameters. Int J Biol Med Res. 2011;2(3):832–4.

  46. Johnstone FD, Prescott RJ, Steel JM, Mao JH, Chambers S, Muir N. Clinical and ultrasound prediction of macrosomia in diabetic pregnancy. Br J Obstet Gynaecol. 1996 Aug;103(8):747–54.

  47. Gu S, An X, Fang L, Zhang X, Zhang C, Wang J, et al. Risk factors and long-term health consequences of macrosomia: a prospective study in Jiangsu Province, China. J Biomed Res. 2012 Jul;26(4):235–40.

  48. Ragnarsdottir LH, Conroy S. Development of macrosomia resulting from gestational diabetes mellitus: physiology and social determinants of health. Adv Neonatal Care. 2010 Feb;10(1):7–12.

  49. Ministry of Public Health (CU). Infomed [Internet]. Havana: Ministry of Public Health (CU); c2015. Entrevistas. Mantiene Cuba la más baja mortalidad infantil de su historia. 2015 Jan 3 [cited 2015 Jul 8]; [about 3 p.]. Available from: http://www.sld .cu/entrevista/2015/01/03/mantiene-cuba-la-mas -baja-mortalidad-infantil-de-su-historia. Spanish.




2020     |     www.medigraphic.com